ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Kurv Yield Premium Strategy Tesla (TSLA) ETF
25.70
+0.8800
3.55%
盘后:
25.70
0.0000
0.00%
17:48 EDT
成交量:
1.41万
成交额:
35.68万
市值:
2,441.50万
市盈率:
- -
高:
25.70
开:
25.01
低:
24.95
收:
24.82
52周最高:
34.29
52周最低:
15.36
股本:
95.00万
流通股本:
95.00万
量比:
1.18
换手率:
1.48%
股息:
8.34
股息率:
32.47%
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻
公告
概念
没有相关数据
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻
赛诺菲(SNY.US)TSLP/IL-13双抗启动COPD II/III期临床
智通财经
·
09/26
基石药业-B(02616)将携CS2015(OX40L/TSLP双特异性抗体)亮相ACAAI 2025
智通财经
·
09/15
大行评级|交银国际:上调康诺亚目标价至78港元 上半年核心品种市场渗透加速
格隆汇
·
08/29
和铂医药公布2025年中期业绩
美通社
·
08/27
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/TSLP"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TSLP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TSLP\",,,,,undefined,":{"symbol":"TSLP","market":"US","secType":"STK","nameCN":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","latestPrice":25.7,"timestamp":1761940800000,"preClose":24.82,"halted":0,"volume":14089,"hourTrading":{"tag":"盘后","latestPrice":25.7,"preClose":25.7,"latestTime":"17:48 EDT","volume":19,"amount":486.9,"timestamp":1761947298530},"delay":0,"floatShares":950000,"shares":950000,"eps":0,"marketStatus":"休市中","change":0.88,"latestTime":"10-31 16:00:00 EDT","open":25.01,"high":25.7,"low":24.95,"amount":356798.232643,"amplitude":0.030218,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1762160400000},"marketStatusCode":7,"adr":0,"exchange":"AMEX","adjPreClose":24.82,"sharesOutstanding":950000,"nav":24.74,"aum":23503000,"dividendRate":0.324704,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":25.7,"preClose":25.7,"latestTime":"17:48 EDT","volume":19,"amount":486.9,"timestamp":1761947298530},"volumeRatio":1.1844780925461926,"impliedVol":0.3686,"impliedVolPercentile":0.56},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TSLP\",,,,,undefined,":{"symbol":"TSLP","floatShares":950000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.1844780925461926,"shares":950000,"dividePrice":8.3449,"high":25.7,"amplitude":0.030218,"preClose":24.82,"low":24.95,"week52Low":15.36,"pbRate":"--","week52High":34.2895,"institutionHeld":0,"latestPrice":25.7,"eps":0,"divideRate":0.324704,"volume":14089,"delay":0,"ttmEps":0,"open":25.01,"prevYearClose":30.27,"prevWeekClose":24.2335,"prevMonthClose":25.7,"prevQuarterClose":24.56,"fiveDayClose":24.2335,"twentyDayClose":24.302,"sixtyDayClose":19.62},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TSLP\",params:#limit:5,,,undefined,":[{"date":"2025-10-08","symbol":"TSLP","amount":0.5,"announcedDate":"2025-10-07","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-08","defaultRemindTime":1759930200000,"name":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-09","payableDate":"2025-10-08","currency":"USD","dateTimestamp":1759896000000,"payDate":"2025-10-09"},{"date":"2025-09-03","symbol":"TSLP","amount":0.45,"announcedDate":"2025-09-02","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-03","defaultRemindTime":1756906200000,"name":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-04","payableDate":"2025-09-03","currency":"USD","dateTimestamp":1756872000000,"payDate":"2025-09-04"},{"date":"2025-08-06","symbol":"TSLP","amount":0.45,"announcedDate":"2025-08-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-06","defaultRemindTime":1754487000000,"name":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-07","payableDate":"2025-08-06","currency":"USD","dateTimestamp":1754452800000,"payDate":"2025-08-07"},{"date":"2025-07-02","symbol":"TSLP","amount":0.45,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-02","defaultRemindTime":1751463000000,"name":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-03","payableDate":"2025-07-02","currency":"USD","dateTimestamp":1751428800000,"payDate":"2025-07-03"},{"date":"2025-06-04","symbol":"TSLP","amount":0.5,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-04","defaultRemindTime":1749043800000,"name":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-05","payableDate":"2025-06-04","currency":"USD","dateTimestamp":1749009600000,"payDate":"2025-06-05"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TSLP\",market:\"US\",,,undefined,":[{"executeDate":"2023-11-22","recordDate":"2023-11-24","paymentDate":"2023-11-27","value":0.5775,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-22","value":0.6664,"currency":"USD"},{"executeDate":"2024-01-24","recordDate":"2024-01-25","paymentDate":"2024-01-26","value":0.5555,"currency":"USD"},{"executeDate":"2024-02-21","recordDate":"2024-02-22","paymentDate":"2024-02-23","value":0.313,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-22","value":0.5189,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TSLP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TSLP\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2570302992","title":"赛诺菲(SNY.US)TSLP/IL-13双抗启动COPD II/III期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2570302992","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570302992?lang=zh_cn&edition=fundamental","pubTime":"2025-09-26 09:05","pubTimestamp":1758848759,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,9月24日,全球临床试验收录网站显示,赛诺菲的TSLP/IL-13双抗Lunsekimig推进至II/III期阶段,针对慢性阻塞性肺病启动了两项II/III期临床试验。研究的主要终点为基线至第48周中重度COPD恶化的年化发生率。此前,赛诺菲曾公布Lunsekimig治疗哮喘的Ib期概念验证研究数据。数据显示,哮喘患者经400mg Lunsekimig治疗28天后,呼出一氧化碳分数较基线显著降低,较安慰剂组降幅为40.9ppb。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349691.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","IE00BFXG1179.USD","TSLP","BK4007","SNY","BK4134","III","BK4588"],"gpt_icon":0},{"id":"2567716532","title":"基石药业-B(02616)将携CS2015(OX40L/TSLP双特异性抗体)亮相ACAAI 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2567716532","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567716532?lang=zh_cn&edition=fundamental","pubTime":"2025-09-15 08:01","pubTimestamp":1757894506,"startTime":"0","endTime":"0","summary":"智通财经APP讯,基石药业-B(02616)发布公告,公司自身免疫与炎症领域管线之一CS2015(OX40L/TSLP双特异性抗体)入选2025年美国过敏,哮喘和免疫学会(ACAAI)年度科学会议,并将以“电子壁报演示+现场口头汇报”的形式展出。本次大会将于11月6日至10日在美国奥兰多举行。CS2015是一款同时靶向OX40L和TSLP的潜在同类首创/同类最佳双特异性抗体,通过双重抑制 Th2介导炎症反应的关键调控因子,为特应性皮炎(AD)、哮喘、慢性阻塞性肺病(COPD)等2型炎症性疾病提供新治疗策略。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1344996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02616","TSLP","BK1574"],"gpt_icon":0},{"id":"2563947470","title":"大行评级|交银国际:上调康诺亚目标价至78港元 上半年核心品种市场渗透加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2563947470","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563947470?lang=zh_cn&edition=fundamental","pubTime":"2025-08-29 11:13","pubTimestamp":1756437220,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["TSLP","DCF","BK1574","02162","BK1583","BK1161","BK1587"],"gpt_icon":0},{"id":"2562775218","title":"和铂医药公布2025年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2562775218","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562775218?lang=zh_cn&edition=fundamental","pubTime":"2025-08-27 22:40","pubTimestamp":1756305600,"startTime":"0","endTime":"0","summary":"中国上海、美国马萨诸塞州剑桥和荷兰鹿特丹2025年8月27日 /美通社/ -- 和铂医药,一家专注于免疫性疾病及肿瘤领域创新药研发的全球生物医药公司,今日公布其2025年中期业绩。报告期内,公司盈利同比增长超50倍,展现出强劲的增长态势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4759969_ZH59969_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["02142","CRS","IE00B19Z4B17.USD","BK1574","TSLP","IE00B7SZL793.SGD","BK1161","IE0031619046.USD","LU0963586101.USD","BK1583","MSS","BK4006","SD","LU2065731478.USD","BK4113","BK4213","IE00B66KJ199.SGD"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TSLP\",params:#limit:6,delay:false,,,undefined,":[]}}